Venetoclax-Navitoclax With Cladribine-based Salvage Therapy in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Clinical trial NCT06007911 · WITHDRAWN
Trial details
- NCT number
- NCT06007911
- Sponsor
- Medical College of Wisconsin
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-31
- Primary completion
- 2025-12-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.